Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies

Cancer Research

Volumn 59, Issue 3, 1999, Pages 728-733

  Bellamy, William T ^a   Richter, Lynne ^a   Frutiger, Yvette ^a   Grogan, Thomas M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; CARCINOGENESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMATOLOGIC NEOPLASMS; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033083962     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med, 333: 1757-1763, 1995.
2. Folkman, J. Tumor angiogenesis. In: J. Mendelssohn, P. M. Howely, M. A. Israel, and L. A. Liotta (eds.), The Molecular Basis of Cancer, pp. 206-235. Philadelphia: W. B. Saunders, 1995.
3. Folkman, J. and Klagsbum, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
4. Madri, J. A., and Williams, S. K. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J. Cell Biol., 97: 153-156, 1983.
5. Brown, L. F. Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. In: I. D. Goldberg and E. M. Rosen (eds.), Regulation of Angiogenesis, pp.233-269. Basel: Birkhauser Verlag, 1997.
6. Olson, T. A., Mohanraj, D., Carson, L. F., and Ramakrishnan, S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res., 54: 276-280, 1993.
7. Ohta, Y., Endo, Y., Tanaka, M., Shimizu, J., Oda, M., Hayashi, Y., Watanabe, Y., and Sasaki, T. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res., 2: 1411-1416, 1996.
8. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
9. Joseph, I., Nelson, J. B., Denmeade, S. R., and Isaacs, J. T. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin. Cancer Res., 3: 2507-2511, 1997.
10. Larcher, F., Robles, A. I., Duran, H., Murillas, R., Quintanilla, M., Cano, A., Conti, C. J., and Jorcano, J. L. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res., 56: 5391-5396, 1996.
11. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
12. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401-409, 1993.
13. Giatromanlaki, A., Koukourakis, M., O'Byrne, K., Fox, S., Whitehouse, R., Talbot, D. C., Harris, A. L., and Gatter, K. C. Prognostic value of angiogenesis in operable non-small cell lung cancer. J. Pathol., 179: 80-88, 1996.
14. Fontanini, G., Bigini, D., Vignati, S., Basolo, F., Mussi, A., Lucchi, M., Chine, S., Angeletti, C. A., Harris, A. L., and Bevillacqua, G. Microvessel count predicts metastalic disease and survival in non-small cell lung cancer. J. Pathol., 177: 57-63, 1995.
15. Meiter, D., Crawford, S. E., Rademaker, A. W., and Cohn, S. Tumor angiogenesis correlates with metastatic disease, n-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol., 14: 405-414, 1996.
16. Kim, J. K., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
17. Fava, R. A., Olsen, N. J., Spencer-Green, G., Yeo, K., Yeo, T., Berse, B., Jackman, R. W., Senger, D. R., Dvorak, H. F., and Brown, L. F. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med., 180: 341-346, 1994.
18. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. Macrophages and angiogenesis. J. Leukocyte Biol., 55: 410-422, 1994.
19. Brown, L. F., Berse, B., Tognazzi, K., Manseau, E. J., van de Water, L., Senger, D. R., Dvorak, H. F., and Rosen, S. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int., 42: 1457-1461, 1992.
20. Iijima, K., Yoshikawa, N., Connolly, D. T., and Nakamura, H. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability, factor. Kidney Int., 44: 959-966, 1993.
21. Verheul, H., Hoekman, K., Luykx-de Baker, S., Eekman, C., Folman, C., Broxterman, H., and Pinedo, H. Platelet: transporter of vascular endothelial cell growth factor. Clin. Cancer Res., 3: 2187-2190, 1997.
22. Frank, S., Huhner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., and Wemer, S. Regulation of vascular endothetial growth factor expression in cultured keratinocytes. J. Biol. Chem., 270: 12607-12613, 1995.
23. Ribatti, D., Vacca, R. D., Nico, B., Fanelli, M., Roncali, L., and Dammacco, F. Angiogencsis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur. J. Haematol., 56: 45-53, 1996.
24. Perez-Atayde, A. R., Sallan, S. E., Tedrow, U., Connors, S., Allred, E., and Folkman, J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphohlastic leukemia. Am. J. Pathol., 750: 815-821, 1997.
25. Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., and Dammacco, F. Bone marrow angiogenesis and progression in multiple myeloma. Br. J. Haematol., 87: 503-508, 1994.
26. Leung, D. W., Cachianes, G., Kuang, W-J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1309, 1989.
27. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
28. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
29. Grogan, T. M., Rangel, C., Rimsza, L., Bellamy, W., Martel, R., McDaniel, D., McGraw, B., Richards, W., Richter, L., Rodgers, P., Rybski, J., Showalter, W., Vela, E., and Zehab, R. Kinetic-mode, automated double-labeled immunohistochemistry and in situ hybridization in diagnostic pathology. Adv. Pathol. Lab. Med., 8: 79-100, 1995.
30. Rimsza, L. M., Vela, E., Frutiger, Y., Rangel, C., Solano, M., Richter, L., Grogan, T. M., and Bellamy, W. T. Rapid automated combined in situ hybridization and immunohistochemistry for sensitive detection of cytomegalovirus RNA and protein in paraffin embedded tissue biopsies. Am. J. Clin. Pathol., 106: 544-548, 1996.
31. Rimsza, L. M., Vela, E., Frutiger, Y. M., Richter, L. C., Grogan, T. M., and Bellamy, W. T. Combined in situ hybridization for automated detection of cytomegalovirus and p53. Mol. Diagnostics. 1: 291-296, 1996.
32. Salmon, S. E., and Cassady, J. R. Plasma cell neoplasms. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.)., Cancer: Principles and Practice of Oncology, Ed. 5, pp. 2344-2387. Philadelphia: J. P. Lippincott Co., 1997.
33. Bataille, R., and Harousseau, J. L. Multiple myeloma. N. Engl. J. Med., 336: 1657-1664, 1997.
34. Klein, B., and Bataille, R. Cytokine network of human multiple myeloma. Hematol. Oncol. Clin. N. Am., 6: 273-284, 1992.
35. Barille, S., Collette, M., Bataille, R., and Amiot, M. Myeloma cells up-regulate interlcukin-6 secretion in osteoblastic cells through cell-to-cell contact but down regulate osteocalcin. Blood, 86: 3151-3159, 1995.
36. Klein, B., Zhang, X., Lu, Z., and Bataille, R. Interleukin-6 in human multiple myeloma. Blood, 85: 863-872, 1995.
37. van Snick, J. Interleukin-6: an overview. Annu. Rev. Immunol., 8: 253-278, 1990.
38. Griffin, J. D., Rambaldi, A., Vellenga, E., Young, D. C., Ostapovicz, D., and Cannistra, S. A. Secretion of interlcukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood, 70: 1218-1221, 1987.
39. Davis, T., Robinson, D., Lee, K., and Kessler, S. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replicating potential: requirement for cell-to-cell interactions and colony-stimulating factors. Blood, 85: 1751-1761, 1995.
40. Fiedler, W., Graeven, I., Ergun, S., Verago, S., Kilic, N., Stockschlader, M., and Hossfeld, D. K. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood, 89: 1870-1875, 1997.
41. Bussolino, F., Wang, J., Defilippi, P., Turrini, F., Sanavio, F., Edgell, C., Aglietta, M., Arese, P., and Mantovani, A. Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature (Lond.), 337: 471-473, 1989.
42. Klein, B., Zhang, X. G., Jordan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., and Bataille, R. Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by inlerleukin-6. Blood, 73: 517-526, 1989.
43. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. Autocrine generation and requirement of BSF/IL-6 for multiple myelomas. Nature (Lond.), 332: 83-85, 1988.
44. Carter, A. Merchav, S., Silvian-Draxler, I., and Tatarsky, I. The role of interleukin-1 and tumor necrosis factor-α in human multiple myetana. Br. J. Haematol., 74: 424-431, 1990.
45. Terman, B. I., Dougher-Vennazen, M., Carrion, M., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187: 1579-1586, 1992.
46. De Vries, C., Escobedo, J., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC), 255: 989-991, 1992.
47. Brown, L. F., Detmar, M., Tognazzi, K., Abu-Jawdeh, G., and Iruela-Arispe, M. L. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Lab. Investig., 76: 245-255, 1997.
48. Yang, X., and Cepko, C. L. Flk-I, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J. Neurosci., 16: 6089-6099, 1996.
49. Guemin, M., Moukadiri, H., Chollet, P., Moro, F., Dutt, K., Malecaze, F., and Poulet, J. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J. Cell Physiol., 164: 385-394, 1995.
50. Teicher, B. A., Holden, S. A., Dupuis, N. P., Kakeji, Y., Ikebe, M., Emi, Y., and Goff, D. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma. Breast Cancer Res. Treat., 36: 227-236, 1995.